Proton Pump Inhibitors (PPIs)

Research Roundup: Covid-19 Immunity, Stomach Acid Susceptibility and More

Aging, Blood Pressure, Colorectal Cancer, Coronavirus Disease 2019 (COVID-19), Coronavirus Tests, Fever, Immunity, Infections, Pain, Proton Pump Inhibitors (PPIs), Research, Scientific studies, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Spain, Stomach, Stomach Acid, The Lancet, University of Michigan

Recently published scientific studies include research into whether Covid-19 immunity might not be possible.

Heartburn symptoms tied to psychological factors in some patients

Gastroesophageal Reflux Disease (GERD), Heartburn, Proton Pump Inhibitors (PPIs), Research, Studies

Heartburn sufferers who do not feel better with standard treatment, but who have no detectable reflux, tend to have greater distress and worse quality of life, according to a new study.

Ironwood’s Potential Blockbuster Drug Meets Main Goals in Mid-Stage Trial

Analysts, Gastroesophageal Reflux Disease (GERD), Proton Pump Inhibitors (PPIs), Shares

Ironwood Pharmaceuticals touted its Phase IIb drug candidate IW-3718 in adult patients with uncontrolled gastroesophageal reflux disease (GERD), but investors seem wary as share prices were down more than 7 percent.